Patterns in Utilization of Healthcare Services and Medications among Patients with Cutaneous Immune-Related Adverse Events - Supplemental Materials
Published: 13 January 2023| Version 1 | DOI: 10.17632/gdwdcsm5z9.1
Supplemental Methods and Supplemental Table 1: Number of instances of systemic steroid and outpatient visit utilizations among patients who developed cutaneous immune-related adverse events.
Brigham and Women's Hospital, Massachusetts General Hospital
Dermatology, Oncology, Immune Checkpoint Inhibitor